We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
iShares 1-3 Year Treasury Bond ETF
SHY
$27B
| $100K | 0.03% |
1,214
+11
| +0.9% | +$904 |
2025 Q2
4 quarters
|
|
127
Walmart Inc
WMT
$951B
| $100K | 0.03% |
879
+85
| +11% | +$10.6K |
2019 Q4
26 quarters
|
|
128
Delta Air Lines
DAL
$50.5B
| $98.3K | 0.03% |
1,049
+2
| +0.2% | +$151 |
2020 Q1
25 quarters
|
|
129
Deere & Co
DE
$174B
| $93.3K | 0.03% |
147
| – | – |
2019 Q4
26 quarters
|
|
130
iShares Morningstar Mid-Cap ETF
IMCB
$1.72B
| $89.6K | 0.03% |
928
-183
| -16% | -$16.7K |
2019 Q4
26 quarters
|
|
131
Zoom
ZM
$27.9B
| $83.9K | 0.03% |
972
| – | – |
2020 Q1
25 quarters
|
|
132
Meta Platforms (Facebook)
META
$1.64T
| $83.8K | 0.03% |
149
-35
| -19% | -$21.4K |
2019 Q4
26 quarters
|
|
133
Coca-Cola
KO
$399B
| $82.7K | 0.03% |
1,018
+176
| +21% | +$13.9K |
2019 Q4
26 quarters
|
|
134
Guardant Health
GH
$22.7B
| $82.5K | 0.03% |
550
| – | – |
2024 Q3
7 quarters
|
|
135
SpaceX
SPCX
$2T
| $82K | 0.03% |
+480
| New | +$81.5K |
2026 Q2
0 quarters
|
|
136
Home Depot
HD
$319B
| $81.9K | 0.03% |
232
+20
| +9% | +$6.51K |
2019 Q4
26 quarters
|
|
137
iShares S&P 500 Growth ETF
IVW
$75.5B
| $78.3K | 0.03% |
570
+1
| +0.2% | +$132 |
2023 Q3
11 quarters
|
|
138
Schwab US Broad Market ETF
SCHB
$44.3B
| $75K | 0.03% |
2,591
+7
| +0.3% | +$196 |
2019 Q4
26 quarters
|
|
139
Vanguard Morningstar Small-Cap ETF
VB
$77.7B
| $74.3K | 0.02% |
245
+1
| +0.4% | +$287 |
2021 Q2
20 quarters
|
|
140
Veeva Systems
VEEV
$52.3B
| $72.2K | 0.02% |
407
| – | – |
2019 Q4
26 quarters
|
|
141
Ford
F
$46.3B
| $71.6K | 0.02% |
5,152
+35
| +0.7% | +$472 |
2019 Q4
26 quarters
|
|
142
Schwab US Large-Cap Growth ETF
SCHG
$62.3B
| $69.6K | 0.02% |
2,058
+2
| +0.1% | +$66 |
2019 Q4
26 quarters
|
|
143
Everus Construction Group
ECG
$4.85B
| $69.5K | 0.02% |
419
| – | – |
2024 Q4
6 quarters
|
|
144
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.1B
| $69.2K | 0.02% |
+875
| New | +$69.2K |
2026 Q2
0 quarters
|
|
145
United Airlines
UAL
$31.8B
| $68K | 0.02% |
500
| – | – |
2022 Q1
17 quarters
|
|
146
Reinsurance Group of America
RGA
$17.2B
| $67.5K | 0.02% |
317
+4
| +1% | +$835 |
2019 Q4
26 quarters
|
|
147
Vanguard S&P 500 Growth ETF
VOOG
$26.7B
| $66.3K | 0.02% |
802
-2
| -0.2% | -$159 |
2025 Q1
5 quarters
|
|
148
DELISTED
Simulations Plus
SLP
| $63.5K | 0.02% |
3,467
+3,100
| +845% | +$47.6K |
2025 Q3
3 quarters
|
|
149
Tyler Technologies
TYL
$16B
| $62.9K | 0.02% |
215
-5
| -2% | -$1.58K |
2023 Q1
13 quarters
|
|
150
Arista Networks
ANET
$217B
| $61.5K | 0.02% |
362
-86
| -19% | -$13.5K |
2022 Q1
17 quarters
|
|
Similar funds
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.